XML 49 R37.htm IDEA: XBRL DOCUMENT v3.25.1

Stockholders’ Equity (Deficit) (Tables)

12 Months Ended

Dec. 31, 2024

Stockholders’ Equity (Deficit) [Abstract]

Schedule of Warrants and Rights Activity

Warrants and Rights activity as of December 31, 2024 were as follows:

		Issue date		Period ended				Contractual life (years)			Warrants/Options Outstanding				Weighted Average Exercise Price				Average Remaining Contractual Life (Years)
Rhove (rollover options) Issued on March 24, 2023		03/04/2023			12/31/2024			2				1,263,000				10.00				0.17
GEM Warrants Issued on October 23, 2023		10/23/2023			12/31/2024			5				1,700,884				371.9				3.81
Follow-on Warrants Issued on November 21, 2023(1)		11/21/2023			12/31/2024			5				2,400,000				1.44				3.89
Warrants outstanding on December 31, 2024												5,363,884				120.93				2.99

(1) In accordance with the anti-dilution provisions of the Follow-On Warrants, the per share exercise price was reduced from $3.90 to $1.44, while the number of shares issuable was increased to approximately 8,333,336, thereby maintaining the aggregate exercise price. This adjustment was reflected in the Company’s filing on February 27, 2025.

X

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-1

+ Details

Name:	us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration